Trial Details
UNKNOWNBasic Information
| Clinical ID | c1379 |
|---|---|
| Identifier | NCT05743010 |
| Trial Title | A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: APL-1401|DRUG: Placebo |
Participant Information
| Sponsor | Jiangsu Yahong Meditech Co., Ltd aka Asieris |
|---|---|
| City | Corona |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-01-26 |
|---|---|
| Primary Completion Date | 2025-03-25 |
| Completion Date | 2025-04-25 |